Division of Oral Medicine and Pathology, School of Dentistry, University of Alberta, 5-531 Edmonton Clinic Health Academy, 11405 87 Ave NW, Edmonton, AB, T6G 1C9, Canada.
Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
J Otolaryngol Head Neck Surg. 2017 May 5;46(1):37. doi: 10.1186/s40463-017-0213-3.
Adenotonsillectomy (AT) is the most commonly performed procedure for sleep disordered breathing (SDB) in pediatrics. However, 20-40% of patients will have persistent signs and symptoms of SDB after AT. Drug-induced sleep endoscopy (DISE) has the potential to individualize surgical treatments and avoid unnecessary or unsuccessful surgeries. The objective of this study was to determine the predictors of failure of DISE-directed adenoidectomy and/or tonsillectomy in otherwise healthy children with SDB.
We retrospectively reviewed a prospective database of children who presented with SDB. All patients underwent preoperative pulse oximetry (PO), followed by DISE with T ± A, The variables documented included demographics, ethnicity, co-morbidities, family history, McGill Oximetry Score (MOS) on PO, as well as findings of collapse and or obstruction on DISE and symptom resolution based on modified Pediatric Sleep Questionnaire (PSQ). The primary outcome was the independent predictors of treatment failure based on multivariate binary logistic regression.
Three hundred eighty-two patients satisfied the inclusion criteria. Based on post-operative modified PSQ, SDB resolved in 259 patients (68%), whereas 123 (32%) had persistent symptoms. On bivariate analysis, neuropsychiatric diagnosis (r = 0.286, p = 0.042), history of sleepwalking or enuresis (r = 0.103, p = 0.044), MOS (r = 0.123, p = 0.033), presence of DNS (r = 0.107, p = 0.036), and presence of laryngomalacia (r = 0.122, p = 0.017) all positively correlated with treatment failure. Small tonsil size on DISE correlated with treatment failure (r = -0.180, p < 0.001). Multivariate analysis identified age greater than 7 years (OR = 1.799, [95% CI 1.040-3.139], p = 0.039), obesity (OR = 2.032, [95% CI 1.043-3.997], p = 0.040), chronic rhinitis (OR = 1.334, [95% CI 1.047-1.716], p = 0.025), deviated nasal septum (OR = 1.745, [95% CI 1.062-2.898], p = 0.031) and tonsil size (OR = 0.575, [95% CI 0.429-0.772], p < 0.01) as independent predictors of treatment failure.
Obese, asthmatic, and children older than seven years are at increased risk of treatment failure after DISE-directed AT. Several DISE findings can independently predict AT failure, including tonsil size, degree of chronic rhinitis, and the presence of a deviated nasal septum, and can be addressed at a second stage. Further research is needed into the role of DISE in surgically naïve patients with SDB, and to compare DISE-directed surgery with the current standard of care.
腺样体切除术(AT)是小儿睡眠呼吸障碍(SDB)最常进行的手术。然而,20-40%的患者在 AT 后仍有持续的 SDB 症状和体征。药物诱导睡眠内窥镜检查(DISE)有可能对手术治疗进行个体化,并避免不必要或不成功的手术。本研究的目的是确定在 otherwise healthy 且患有 SDB 的儿童中,哪些因素可预测 DISE 指导下的腺样体切除术和/或扁桃体切除术的失败。
我们回顾性分析了一个以 SDB 为特征的前瞻性数据库中患儿的资料。所有患者均行术前脉搏血氧饱和度(PO)检查,随后进行 T ± A 的 DISE。记录的变量包括人口统计学、种族、合并症、家族史、PO 上的 McGill 血氧计评分(MOS),以及 DISE 上的塌陷和/或阻塞发现,以及根据改良小儿睡眠问卷(PSQ)的症状缓解情况。主要结局是基于多元二项逻辑回归的治疗失败的独立预测因素。
382 名患者符合纳入标准。根据术后改良 PSQ,259 名患者(68%)SDB 缓解,而 123 名患者(32%)仍有持续症状。在单变量分析中,神经精神诊断(r=0.286,p=0.042)、梦游或遗尿史(r=0.103,p=0.044)、MOS(r=0.123,p=0.033)、DNS 存在(r=0.107,p=0.036)和喉软骨软化存在(r=0.122,p=0.017)均与治疗失败呈正相关。DISE 上小扁桃体大小与治疗失败相关(r=-0.180,p<0.001)。多变量分析确定年龄大于 7 岁(OR=1.799,[95%CI 1.040-3.139],p=0.039)、肥胖(OR=2.032,[95%CI 1.043-3.997],p=0.040)、慢性鼻炎(OR=1.334,[95%CI 1.047-1.716],p=0.025)、鼻中隔偏曲(OR=1.745,[95%CI 1.062-2.898],p=0.031)和扁桃体大小(OR=0.575,[95%CI 0.429-0.772],p<0.01)是治疗失败的独立预测因素。
肥胖、哮喘和 7 岁以上的儿童在 DISE 指导下的 AT 后治疗失败的风险增加。几项 DISE 发现可独立预测 AT 失败,包括扁桃体大小、慢性鼻炎的程度和鼻中隔偏曲的存在,并可在第二阶段解决。需要进一步研究 DISE 在 SDB 的初治患者中的作用,并比较 DISE 指导下的手术与当前的标准治疗。